Description
Created On: 2020-07-15
Record Count: 3
Primary Industries
- Medical
- Pain
- Delivery
- Device
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 7524
Licensee shall have the right to enter into licensing, joint venture and acquisition Agreements with clinics that provide pain management services under the direction of physicians who are properly Licensed to practice medicine and qualified to treat patients using the Protocol in the territory; establish pharmacies that will be within or associated with clinics acquired by Licensor as permitted by the regulations enforced by the applicable governments within the territory; and take such steps that are deemed necessary to develop the business of pain management in the territory.
The Protocol is a new, proprietary medical approach for the treatment and management of chronic pain which consists of the following personalized treatment plans;
o Physical examination by the attending doctor, blood testing and urine drug screening to:
o
provide accurate diagnoses of the type and source of pain;
o
establish baseline drug profiles;
o
monitor treatment progress; and
o
maintain post-treatment support.
o Education for patients about the specific nature of their chronic pain.
o On-going interaction to ensure and support patient adherence to beneficial behavioral changes such as keeping regular hours to enhance sleep patterns.
o Relaxation training to reduce the effects or stress and anxiety which can aggravate pain.
o Specific amino acids and other dietary supplements to restore and maintain normal brain chemistry.
o Reduction of cellular inflammation through:
o
patient pain diary and tracking of food intake and activities;
o
identification of pain triggers and food sensitivities in the diet; and
o
proper nutrition to eliminate problem foods and provide better nutrition.
o Reduction of joint inflammation through:
o
dietary changes;
o
topical medications; and
o
light exercise regimens.
o Day and night time regimens to promote restorative sleep.
o Use electrotherapy stimulation (“CESâ€) to promote production and release of endorphins (Han et al., 1991; Han, 2004).
o Topical medications for pain relief.
o On-going counseling, telephone and on-line support and regular checkups to:
o
review progress and maintain flexible, individualized programs;
o
allow changes in the treatment protocols to achieve optimal results; and
o
promote continuing patient compliance and contact.
IPSCIO Record ID: 4665
IPSCIO Record ID: 166205
The SynchroMed system is the only externally programmable, implantable, drug infusion system available today. Using telemetry, the clinician can program its pump to deliver precise doses of medication at specific times to provide optimum therapy for each patient. It is widely used with morphine sulfate to block pain signals traveling to the brain and is also used to treat severe spasticity associated with multiple sclerosis, spinal cord injury, cerebral palsy, and traumatic brain injury. Clinical trials are expected to be initiated in 1998.
